“…Over the past few years the naturally occurring muscarinic agonist arecoline [9] (1-methyl-5-methoxycarbonyl-1,2,3,6-tetrahydropyridine) has been a template for the preparation of new muscarinic ligands bearing a heterocyclic ring in substitution of the labile arecoline ester group.Thus arecoline bioisosteres bearing a thiadiazole [10,11], oxadiazole [12], tetrazole, or 1,2,3-triazole [13] ring were studied for affinities to M 1 -M 3 receptors, while at present the corresponding pyrazoles [14] and [1,2,4]triazoles were only partially investigated.…”